Download our type 2 diabetes risk self assessment

Medicare Expands CGM Access and Shield Launches Dexcom G7.

On April 6, 2023, the FDA issued a Class I Recall of Abbott’s FreeStyle Libre®, FreeStyle Libre® 14 day, and FreeStyle Libre® 2 Readers in the United States. A medical device recall means a firm’s removal or correction of a medical device. In this case, Abbott is correcting the product labeling and not physically removing… Continue reading Abbott Issues Voluntary Urgent Medical Device Correction Notice for FreeStyle Libre Readers

Providing medical supplies since 1957.

by Ami Cole, Plan President at Molina Healthcare of Ohio, Inc. | Ohio Association of Health Plans Ohio’s Medicaid Managed Care plans work collaboratively every day to help support the over 3 million Medicaid recipients we are privileged to serve. In this effort, we have learned about the many challenges members face in accessing care… Continue reading Working Together, Plans Bring Better Diabetes Care

Clinicians should consider continuous glucose monitoring for any person with diabetes to assess their time spent in the recommended glucose range (TIR).

Worried about COVID-19? Here's the latest information for people with type 1 diabetes, from the experts at the Juvenile Diabetes Research Foundation (JDRF).

Medtech companies Dexcom and Abbott each partnered with Insulet to integrate their technologies to develop the new artificial pancreas.

In this article, we look at the function of carbohydrates, as well as where they come from, how the body processes them, and which ones to choose.

A new study from Joslin Diabetes Center proved that certain biological protective factors play a role in preventing diabetic kidney disease in some people.